Lower patients' cholesterol now
- 20 May 1995
- Vol. 310 (6990) , 1280-1281
- https://doi.org/10.1136/bmj.310.6990.1280
Abstract
Clinical decisions are rarely black or white. More often than not they are made with incomplete knowledge. This is certainly true in the prevention of cardiovascular disease. No one would challenge a policy aimed at reducing cigarette smoking, even in the absence of formal evidence from trials of a positive effect on the incidence of coronary …Keywords
This publication has 7 references indexed in Scilit:
- Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.Circulation, 1994
- Pravastatin, lipids, and major coronary eventsThe American Journal of Cardiology, 1994
- Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.Circulation, 1994
- Cholesterol lowering and mortality: the importance of considering initial level of risk.BMJ, 1993
- Cholesterol and total mortality: need for larger trials.BMJ, 1992
- Might treatment of hypercholesterolaemia increase non-cardiac mortality?The Lancet, 1991
- The Value of Lowering Cholesterol after Myocardial InfarctionNew England Journal of Medicine, 1990